SynthesisFrontiers in oncology2026

Efficacy and safety of tyrosine kinase inhibitor combination therapy for glioblastoma: a meta-analysis with trial sequential analysis of randomized controlled trials.

Pan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.